152
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Pulmonary Peptide Delivery: Effect of Taste-Masking Excipients on Leuprolide Suspension Metered-Dose Inhalers

, , , &
Pages 521-530 | Received 28 Mar 1999, Accepted 01 Mar 2001, Published online: 04 Apr 2002

REFERENCES

  • Fujino M., Fukuda T., Shinagawa S.R., Kobayashi S., Yamazaki I., Nakayama R., Seely J.H., White W.F., Rippel R.H. Synthetic Analogs of Luteinizing Hormone Releasing Hormone (LH-RH) Substituted in Position 6 and 10. Biochem. Biophys. Res. Commun. 1974; 60: 406–413
  • Fujino M., Yamazaki I., Kobayashi S., Fukuda T., Shinagawa S.R., White W.F., Rippel R.H. Some analogs of luteinizing hormone releasing hormone (LH-RH) having intense ovulation-inducing activity. Biochem. Biophys. Res. Commun. 1974; 57: 1248–1256
  • Leuprolide Versus Diethylstilbestrol for Metastatic Prostate Cancer. New Engl. J. Med. 1984; 311: 1281–1286
  • Lemay A., Maleux R., Faure N., Jean C., Fazekas A.T.A. Efficacy and Safety of LH-RH Agonist Treatment in 10 Patients with Endometriosis. J. Steroid Biochem. 1984; 20(A30)1379
  • Okada H., Yamazaki I., Ogawa I., Hirai S., Yashiki T., Mima H. Vaginal Absorption of a Potent Luteinizing Hormone-Releasing Hormone Analog (Leuprolide) in Rats. I. Absorption by Various Routes and Absorption Enhancement. J. Pharm. Sci. 1982; 71: 1367–1371
  • Adjei A., Garren J. Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers. Pharm. Res. 1990; 7: 565–569
  • Adjei A., Sundberg D., Miller J., Chun A. Bioavailability of Leuprolide Acetate Following Nasal and Inhalation Delivery to Rats and Healthy Human. Pharm. Res. 1992; 9: 244–249
  • Adjei A., Love S., Johnson E., Diaz G., Greer G., Haviv F., Bush E. Effect of Formulation Adjuvants on Gastrointestinal Absorption of Leuprolide Acetate. J. Drug Targeting 1993; 1: 251–258
  • FuLu M., Lee D., Subba Rao G. Percutaneous Absorption Enhancement of Leuprolide. Pharm. Res. 1992; 9: 1575–1579
  • Byron P.R. P.R. ByronAerosol Formulation, Generation, and Delivery Using Metered Systems. Respiratory Drug Delivery, . CRC Press, New York 1990; 167–205
  • Newman S.P., Moren F., Pavia D., Corrado O., Clarke S.W. The Effect of Changes in Metered Volume and Propellant Vapour Pressure on the Deposition of Pressurized Inhalation Aerosols. Int. J. Pharm. 1982; 11: 337–344
  • , Adjei, A.; Lee, D.; Hlinak, A.J. Apparatus for the Continuous Milling of Aerosol Pharmaceutical Formulations in Aerosol Propellants. US Patent #5,687,920, 1997.
  • Marple V.A., Olson B.A., Miller N.C. A Low-Loss Cascade Impactor With Stage Collection Cups: Calibration and Pharmaceutical Applications. Aerosol. Sci. Technol. 1995; 22: 124–128
  • Nasr M.M., Allgire J.F. Loading Effect on Particle Size Measurement by Inertial Sampling of Albuterol Metered Dose Inhalers. Pharm. Res. 1995; 12: 1677–1681
  • , Recommendations of the USP Advisory Panel on Aerosols on the USP General Chapters on Aerosols (601) and Uniformity of Dosage Units (905). Pharmacopoeial Forum. 1994, 20, 7477–7503.
  • Sutherland J.W., Menon G.N. HPLC of Leuprolide Acetate in Injectable Solution. J. Liq. Chromatogr. 1987; 10: 2281–2289
  • Adjei A., Doyle R., Pratt M., Finley R., Johnson E. Bioavailability of Leuprolide Following Intratracheal Administration to Beagle Dogs. Int. J. Pharm. 1990; 61: 135–144
  • Adjei A., Hui J., Finley R., Lin T., Lancaster J., Fort F. Pulmonary Bioavailability of Leuprolide Acetate Following Multiple Dosing to Beagle Dogs: Some Pharmacokinetic and Preclinical Issues. Int. J. Pharm. 1994; 107: 57–66
  • Gupta P.K., Hickey A.J. Contemporary Approaches in Aerosolized Drug Delivery to the Lung. J. Control. Rel. 1991; 17: 129–148
  • Hickey A.J., Evans R.M. A.J. HickeyAerosol Generation from Propellant-Driven Metered Dose Inhaler. Inhalation Aerosol—Physical and Biological Basis for Therapy, . Marcel Dekker, New York 1996; 417–440
  • Gonda I. Development of a Systematic Theory of Suspension Aerosols. I. A Framework to Study the Effects of Aggregation on the Aerodynamic Behavior of Drug Particles. Int. J. Pharm. 1985; 27: 99–103

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.